Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: Influence on cumulative hospital antibiograms

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wolfensberger, Aline ^a   Sax, Hugo ^a   Weber, Rainer ^a   Zbinden, Reinhard ^b   Kuster, Stefan P ^a   Hombach, Michael ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SWITZERLAND; TERTIARY CARE CENTER; TREND STUDY; WARD;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EUROPE; GUIDELINES AS TOPIC; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PATIENTS' ROOMS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SWITZERLAND; TERTIARY CARE CENTERS;

EID: 84891393001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079130     Document Type: Article

References (27)

1. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW et al. (2003) European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 52: 145-148. doi:10.1093/jac/dkg312. PubMed: 12837738.
2. Clinical and Laboratory Standards Insitute (2009) Performance Standards for Antimicrobial Susceptebility Testing: Nineteenth Informational Supplement M100-S19. Wayne, PA: CLSI..
3. European Commitee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Versions 1.3 and 2.0. Available: http://www.eucast.org/antimicrobial-susceptibility-testing/previous- versions-of-tables/. Accessed 23 May 2013.
4. Hombach M, Bloemberg GV, Böttger EC (2012) Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother England, 67: 622-632. PubMed: 22167240.
5. van der Bij AK, van Dijk K, Muilwijk J, Thijsen SF, Notermans DW et al. (2012) Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia. Clin Microbiol Infect 18: E466-E472. doi:10.1111/j.1469-0691.2012.03996.x. PubMed: 22925456.
6. Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Hsueh PR (2010) Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study. Int J Antimicrob Agents Neth, 36: 293-294. PubMed: 20598511.
7. Rodríguez-Baño J, Picón E, Navarro MD, López-Cerero L, Pascual A (2012) Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect 18: 894-900. doi:10.1111/j.1469-0691.2011.03673.x. PubMed: 21985560.
8. Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P et al. (2001) Surveillance of antimicrobial resistance - what, how and whither? Clin Microbiol Infect 7: 316-325. doi:10.1046/j.1198-743x.2001.00239.x. PubMed: 11442565.
9. Pakyz AL (2007) The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 27: 1306-1312. doi:10.1592/phco.27.9.1306. PubMed: 17723084.
10. Marchese A, Esposito S, Barbieri R, Bassetti M, Debbia E (2012) Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections? BMC Infect Dis England, 12: 181. PubMed: 22866984.
11. Kuster SP, Ruef C, Zbinden R, Gottschalk J, Ledergerber B et al. (2008) Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. J Antimicrob Chemother England, 62: 1451-1461. PubMed: 18776189.
12. Rhomberg PR, Fritsche TR, Sader HS, Jones RN (2006) Antimicrobial susceptibility pattern comparisons among intensive care unit and. Diagn Microbiol Infect Dis 56: 57-62. doi:10.1016/j.diagmicrobio.2005.12.009. PubMed: 16631338.
13. Hindler JF, Stelling J (2007) Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 44: 867-873. doi:10.1086/511864. PubMed: 17304462.
14. European Committee on Antimicrobial Susceptibility Testing EUCAST Disk diffusion manual 2013. http://www.eucast.org/eucast-susceptibility-testing/disk- diffusion-methodology. Accessed 7 August 2013
15. Hombach M, Böttger EC, Roos M (2013) The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin Microbiol Infect 19: E59-E71. doi:10.1111/1469-0691.12090. PubMed: 23210931.
16. Clinical and Laboratory Standards Institute (2008). Developement of in vitro susceptibility testing criteria and quality control parameters: approved guideline, 3rd edn. Wayne, PA: CLSI. CLSI Document M23-A3
17. Kronvall G, Giske CG, Kahlmeter G (2011) Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. Int J Antimicrob Agents 38: 281-290. doi:10.1016/j.ijantimicag.2011.04.006. PubMed: 21640560.
18. European Committee on Antimicrobial Susceptibility Testing (2010) Setting breakpoints for new agents, EUCAST SOP. I.0. Available: http://www.eucast.org/ documents/sops/. Accessed 23 May 2013.
19. European Committee on Antimicrobial Susceptibility Testing EUCAST rationale documents. Available: http://www.eucast.org/documents/rd/. Accessed 7 August 2013
20. CLSI, editor (2010), Clinical and Laboratory Standards Insitute. Performance Standards for Antimicrobial Susceptebility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA.
21. CLSI, editor (2011), Clinical and Laboratory Standards Insitute. Performance Standards for Antimicrobial Susceptebility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA.
22. CLSI, editor (2012), Clinical and Laboratory Standards Insitute. Performance Standards for Antimicrobial Susceptebility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA.
23. CLSI, editor (2013), Clinical and Laboratory Standards Insitute. Performance Standards for Antimicrobial Susceptebility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA.
24. European Commitee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 3.0. Available: http://www.eucast.org/clinical-breakpoints/. Accessed 23 May 2013
25. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al. (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52: e103-e120. doi:10.1093/cid/ciq257. PubMed: 21292654.
26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44: S27-S72. doi:10.1086/511159. PubMed: 17278083.
27. Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I et al. (2006) Comparison of unit-specific and hospital-wide antibiograms: potential. Infect Control Hosp Epidemiol 27: 682-687. doi:10.1086/505921. PubMed: 16807842.